Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

ENDRA Life Sciences Inc. (NDRA) vs XWELL, Inc. (XWEL)

ENDRA Life Sciences Inc. and XWELL, Inc. are both Diagnostics & Research companies. ENDRA Life Sciences Inc. is the larger, with a market value of $8.9M against $7.6M — 1.2× the size. ENDRA Life Sciences Inc. has the higher net margin (0.00% vs −117.8%) and the lower return on invested capital (−539.9% vs 0.00%). Across the 15 metrics below, ENDRA Life Sciences Inc. leads on 9 and XWELL, Inc. on 6.

Valuation

Metric NDRA XWEL Diagnostics & Research median
P/E n/m n/m 33.95
P/S 22.35 0.27 4.87
P/B 1.27 0.92 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m n/m 25.20
EV/Sales 7.61 0.30 5.66
Earnings yield (104.64%) (597.75%) (1.75%)
Free cash flow yield (98.06%) (178.41%) (0.13%)

Profitability

Metric NDRA XWEL Diagnostics & Research median
Gross margin 0.00% 34.34% 50.89%
Operating margin 0.00% (61.31%) (8.57%)
Net margin 0.00% (117.83%) (6.37%)
Free cash flow margin 0.00% (47.65%) 0.00%
Return on equity (152.04%) (557.21%) (2.92%)
Return on assets (110.08%) (155.10%) (6.71%)
Return on invested capital (539.89%) 0.00% 0.00%

Growth

Metric NDRA XWEL Diagnostics & Research median
Revenue growth (TTM) — (7.58%) 7.69%
EPS growth (last fiscal year) 84.32% (38.80%) —
Revenue growth, 5-year CAGR — 28.35% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NDRA XWEL Diagnostics & Research median
Debt to equity 0.00 0.00 0.11
Current ratio 7.10 2.27 2.02
Net debt to EBITDA 0.14 (0.08) 0.78

Dividend

Metric NDRA XWEL Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric NDRA XWEL Diagnostics & Research median
Market cap 8.89m 7.64m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack